Indivior stock hits 52-week high at 23.44 USD
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Indivior PLC (INDV)
Indivior PLC stock price live, this page displays NASDAQ INDV stock exchange data. View the INDV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Indivior PLC real time stock price chart below.
What Is the Indivior PLC Stock Price Today?
The Indivior PLC stock price today is 23.95.
What Is the Stock Symbol for Indivior PLC?
The stock symbol for Indivior PLC is ""INDV.""
What Stock Exchange Does Indivior PLC Trade On?
Indivior PLC is listed and trades on the NASDAQ stock exchange.
Is Indivior PLC a Good Stock to Buy?
Determining whether Indivior PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INDV quote. (ISIN: GB00BN4HT335)
What Is the Indivior PLC Stock Price Today?
The Indivior PLC stock price today is 23.95.
What Is the Stock Symbol for Indivior PLC?
The stock symbol for Indivior PLC is ""INDV.""
What Stock Exchange Does Indivior PLC Trade On?
Indivior PLC is listed and trades on the NASDAQ stock exchange.
Is Indivior PLC a Good Stock to Buy?
Determining whether Indivior PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INDV quote. (ISIN: GB00BN4HT335)
23.95
+0.47(+2.00%)
Real-time Data·
Fair Value
An estimate of a Indivior's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.14
24.00
52 wk Range
7.33
24.00
INDV Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week High
1/2
Fair Value
An estimate of a Indivior's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.1424.00
52 wk Range
7.3324.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
INDV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Indivior's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
27.33
Upside
+14.13%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Indivior stock hits 52-week high at 22.36 USD
- Investing.com
- Indivior stock hits 52-week high at 17.56 USD
- Investing.com
- Indivior NAQ receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Indivior stock hits 52-week high at 23.44 USD
- Investing.com
- Indivior stock hits 52-week high at 22.36 USD
- Investing.com
- Indivior NAQ receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Indivior NAQ receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Indivior PLC Company Profile
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Indivior PLC Earnings Call Summary for Q2/2025
- Q2 EPS of $0.51, beating $0.24 forecast; revenue at $302M, up 1% YoY; stock surged 21.15% pre-market
- SUBLOCADE revenue grew 9% YoY; full-year 2025 guidance raised to $1.03-$1.08B revenue, $275-$300M adjusted EBITDA
- CEO emphasized addressing core cost structure; CFO noted organization complexity and high costs for company size
- Company maintains 81.6% gross profit margin, 4.1% revenue growth over 12 months; Financial Health Score 'GREAT'
- Management assured no significant pricing pressure in July; focus on commercial channel expansion and Medicaid
Last Updated: 31/07/2025, 15:18
Read Full TranscriptCompare INDV to Peers and Sector
Metrics to compare | INDV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINDVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 56.4x | 12.7x | −0.6x | |
PEG Ratio | 0.37 | 0.12 | 0.00 | |
Price/Book | −11.6x | 2.5x | 2.6x | |
Price / LTM Sales | 2.5x | 3.2x | 3.3x | |
Upside (Analyst Target) | 17.1% | 21.9% | 40.1% | |
Fair Value Upside | Unlock | 17.1% | 5.3% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 27.33
(+14.13% Upside)
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
0.51 / 0.24
Revenue / Forecast
302.00M / 241.67M
People Also Watch
FAQ
What Stock Exchange Does Indivior Trade On?
Indivior is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Indivior?
The stock symbol for Indivior is "INDV."
What Is the Indivior Market Cap?
As of today, Indivior market cap is 2.93B.
What Is Indivior's Earnings Per Share (TTM)?
The Indivior EPS (TTM) is 0.42.
When Is the Next Indivior Earnings Date?
Indivior will release its next earnings report on 22 Oct 2025.
From a Technical Analysis Perspective, Is INDV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Indivior Stock Split?
Indivior has split 0 times.
How Many Employees Does Indivior Have?
Indivior has 1000 employees.
What is the current trading status of Indivior (INDV)?
As of 20 Aug 2025, Indivior (INDV) is trading at a price of 23.95, with a previous close of 23.48. The stock has fluctuated within a day range of 23.14 to 24.00, while its 52-week range spans from 7.33 to 24.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.